1. Home
  2. ENVB vs ASTI Comparison

ENVB vs ASTI Comparison

Compare ENVB & ASTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENVB
  • ASTI
  • Stock Information
  • Founded
  • ENVB 1994
  • ASTI 2005
  • Country
  • ENVB United States
  • ASTI United States
  • Employees
  • ENVB N/A
  • ASTI N/A
  • Industry
  • ENVB Biotechnology: Pharmaceutical Preparations
  • ASTI Semiconductors
  • Sector
  • ENVB Health Care
  • ASTI Technology
  • Exchange
  • ENVB Nasdaq
  • ASTI Nasdaq
  • Market Cap
  • ENVB 3.1M
  • ASTI 2.9M
  • IPO Year
  • ENVB N/A
  • ASTI N/A
  • Fundamental
  • Price
  • ENVB $1.15
  • ASTI $1.68
  • Analyst Decision
  • ENVB Strong Buy
  • ASTI
  • Analyst Count
  • ENVB 1
  • ASTI 0
  • Target Price
  • ENVB $10.00
  • ASTI N/A
  • AVG Volume (30 Days)
  • ENVB 179.6K
  • ASTI 267.6K
  • Earning Date
  • ENVB 08-11-2025
  • ASTI 08-12-2025
  • Dividend Yield
  • ENVB N/A
  • ASTI N/A
  • EPS Growth
  • ENVB N/A
  • ASTI N/A
  • EPS
  • ENVB N/A
  • ASTI N/A
  • Revenue
  • ENVB N/A
  • ASTI $51,917.00
  • Revenue This Year
  • ENVB N/A
  • ASTI N/A
  • Revenue Next Year
  • ENVB N/A
  • ASTI N/A
  • P/E Ratio
  • ENVB N/A
  • ASTI N/A
  • Revenue Growth
  • ENVB N/A
  • ASTI N/A
  • 52 Week Low
  • ENVB $1.01
  • ASTI $1.10
  • 52 Week High
  • ENVB $8.95
  • ASTI $10.00
  • Technical
  • Relative Strength Index (RSI)
  • ENVB 35.60
  • ASTI 42.87
  • Support Level
  • ENVB $1.18
  • ASTI $1.65
  • Resistance Level
  • ENVB $1.26
  • ASTI $1.94
  • Average True Range (ATR)
  • ENVB 0.08
  • ASTI 0.19
  • MACD
  • ENVB -0.02
  • ASTI -0.05
  • Stochastic Oscillator
  • ENVB 3.10
  • ASTI 4.81

About ENVB Enveric Biosciences Inc.

Enveric Biosciences Inc is a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company's program, EB-003, is a first-in-class approach to the treatment of difficult-to-address mental health disorders designed to promote neuroplasticity without inducing hallucinations in the patient. The company is also developing EB-002, formerly EB-373, a next-generation synthetic prodrug of the active metabolite, psilocin, which is being studied as a treatment for psychiatric disorders.

About ASTI Ascent Solar Technologies Inc.

Ascent Solar Technologies Inc is engaged in the manufacturing, and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.

Share on Social Networks: